Drug Channels

Expert insights by Dr. Adam J. Fein on pharmaceutical economics and the drug distribution system (RSS feed)

 

Beyond Throughput: Building Reverification Strategies That Safeguard Access
2025-07-25 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.)

Today’s guest post comes from Gregory Morris, Chief Strategy Officer at CareMetx.

Gregory examines how Annual Reverification (AR) processes must evolve in response to changing payer dynamics and increasing benefit complexity. Rather than focusing solely on throughput and operational efficiency, he argues for the importance of more nuanced strategies that help ensure patients maintain access to therapy—even when coverage details shift behind the scenes.

To learn about CareMetx’s solution, download the case study: Rethinking Annual Reverification: A Strategic, Multi-Layered Approach to Protecting Patient Access.

Read on for Gregory’s insights.
Read more »
       

 

Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative.